Overview: Citric Acid TestIntroduction: The Citric Acid Test measures citric acid levels in urine to assess kidney stone risk or metabolic disorders, helping prevent painful kidney stones or related complications. Affecting 1 in 10 people with kidney stones, these conditions pose diagnostic challenges due to recurring episodes. Following 2023 National Kidney Foundation (NKF) guidelines, it uses enzymatic assay for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, prevention planning, and improving outcomes in urology.
Other Names: Urine Citric Acid Test, Citrate Level Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Citric acid testing began in the 1960s with research by Pak, who linked it to kidney stones. Enzymatic assay advancements in the 1990s by Roche improved detection, surpassing earlier titration methods.
Purpose: Measures citric acid levels to assess kidney stone risk, guides dietary therapy or citrate supplementation, and evaluates patients with stone history, aiming to prevent recurrence.
Test Parameters: Citric acid levels
Pretest Condition: No special preparation required. Collect urine or plasma. Report history of kidney stones.
Specimen: Urine (sterile container, 5-20 mL), Plasma (NaHep, 2-4 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document history of kidney stones. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., obstruction), and sample collection risks.
Procedural Considerations: Uses enzymatic assay to measure citric acid, requiring labs with spectrophotometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Low levels indicate stone risk, guiding therapy. Early intervention might prevent stones, while untreated cases lead to complications. Normal levels may require calcium tests.
Specialist Consultation: Consult a urologist for interpretation.
Additional Supporting Tests: Urine calcium, 24-hour urine collection, or imaging to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with symptoms needed. False positives possible with sample issues.
References: NKF Guidelines, 2023; Kidney International, Pak CYC, 2022.
